Your browser doesn't support javascript.
loading
Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial.
Sundar, Raghav; Barr Kumarakulasinghe, Nesaretnam; Huak Chan, Yiong; Yoshida, Kazuhiro; Yoshikawa, Takaki; Miyagi, Yohei; Rino, Yasushi; Masuda, Munetaka; Guan, Jia; Sakamoto, Junichi; Tanaka, Shiro; Tan, Angie Lay-Keng; Hoppe, Michal Marek; Jeyasekharan, Anand D; Ng, Cedric Chuan Young; De Simone, Mark; Grabsch, Heike I; Lee, Jeeyun; Oshima, Takashi; Tsuburaya, Akira; Tan, Patrick.
Afiliação
  • Sundar R; Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Hospital, Singapore.
  • Barr Kumarakulasinghe N; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Huak Chan Y; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore.
  • Yoshida K; The N.1 Institute for Health, National University of Singapore, Singapore.
  • Yoshikawa T; Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Hospital, Singapore.
  • Miyagi Y; Biostatistics Unit, Yong Loo Lin School of Medicine, National University Singapore, Singapore.
  • Rino Y; Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Masuda M; Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Guan J; Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Sakamoto J; Department of Surgery, Yokohama City University, Yokohama, Japan.
  • Tanaka S; Department of Surgery, Yokohama City University, Yokohama, Japan.
  • Tan AL; Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Hoppe MM; Tokai Central Hospital, Kakamigahara, Japan.
  • Jeyasekharan AD; Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ng CCY; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore.
  • De Simone M; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Grabsch HI; Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Hospital, Singapore.
  • Lee J; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Oshima T; Laboratory of Cancer Epigenome, Department of Medical Sciences, National Cancer Centre Singapore, Singapore.
  • Tsuburaya A; InSilico Genomics, Phoenix, Arizona, USA.
  • Tan P; Department of Pathology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.
Gut ; 71(4): 676-685, 2022 04.
Article em En | MEDLINE | ID: mdl-33980610
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Gut Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Gut Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura País de publicação: Reino Unido